Subscribe
Endometrial and acute myeloid leukemia cancer genomes characterized
May 1, 2013The characterization of acute myeloid leukemia and endometrial cancer are the latest results of The Cancer Genome Atlas Research Network’s efforts to sequence the genomes of 20 major cancers. The photo above shows technicians from The Genome Institute at Washington University in St. Louis.
Cancer immunotherapy in children: How does it differ from approaches in adults?
April 8, 2013
More often than not, cancer immunotherapies that work in adults are used in modified ways in children. Seldom are new therapies developed just for children, primarily because of the small number of pediatric patients relative to the adult cancer patient population. Depicted are members of NCI’s Pediatric Oncology Branch. From left: Drs. Crystal Mackall, Daniel Lee, and Alan Wayne
Understanding the Role of Self-Image in Cancer Recovery
March 27, 2013
A year ago, Colleen Williams was into the natural look. She seldom bothered to put on makeup and she let her long, wavy, brown hair flow free. Cancer treatment changed that. These days, when she feels well enough to go to work, Williams wears her “cute hat” to cover her newly-balding head and takes a little extra time in the morning to pencil in her thinning brows and apply concealer to make her skin look a little less gray.
The Living Lab: Navigating into cells
December 6, 2012
The Living Lab is an innovative partnership between NIH institutes and private industry, to use cutting-edge electron microscopy to navigate into cells and viruses. Sriram Subramaniam, Ph. D., director of the NIH component of the Living Lab, is pictured holding a model of the three-dimensional structure of a portion of a protein complex from the surface of HIV.
Leukemia, the first and second time around
February 14, 2013
Sometimes rising or falling trends in cancer rates can mask more complicated scientific aspects of the disease. Consider a relatively rare form of leukemia known as AML that predominantly affects middle-age and elderly adults. Based on data from NCI and others recently released in the Annual Report to the Nation, an estimated 14,000 people will develop AML in the United States in 2013, and an estimated 10,000 people will die from it.
